Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Director/PDMR Shareholding

27 Sep 2017 16:59

RNS Number : 0162S
Cello Group plc
27 September 2017
 

27 September 2017

Cello Group plc

 ("Cello" or the "Company")

 

Director/PDMR Shareholding

 

The Company has been notified that on 27 September 2017 Mark Bentley, Group Finance Director, sold and then re-purchased 110,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), in order to transfer the Ordinary Shares to Mr Bentley's SIPP. The sale price was 127.50 pence per share and the purchase price was 127.53 pence per share.

The sale and purchase has no effect on the total number of Ordinary Shares held by Mr Bentley and, following this transaction, Mr Bentley remains beneficially and non-beneficially interested in 442,518 Ordinary Shares, representing approximately 0.4 per cent. of the Company's issued ordinary share capital.

The Company has also received notification that on 27 September 2017, Jane Shirley, a director of Cello Health, exercised share options over 20,000 Ordinary Shares for an exercise price of 10 pence per share, and subsequently sold the 20,000 Ordinary Shares for a price of 127 pence per share. In addition, on 26 September 2017, Alistair Shirley, a person closely associated with Jane Shirley, sold 421 Ordinary Shares at a price of 129 pence per share.

Following the above transactions, Jane Shirley and her persons closely associated hold 78,000 Ordinary Shares, representing approximately 0.1% of the Company's issued ordinary share capital.

 

Enquiries:

 

Cello Group

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Finance Director

Cenkos Securities

0207 397 8900

Bobbie Hilliam

Harry Hargreaves

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.50p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,250

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.53p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,283

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Exercise of options over Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

10p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£2,000

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

Outside trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£25,400

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Alistair Shirley

2

Reason for the notification

a)

Position/status

Person closely associated with Jane Shirley

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

129p

421

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

421

 

£543.09

e)

Date of the transaction

26 September 2017

f)

Place of the transaction

XLON

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUBVVRBWAKUAR
Date   Source Headline
17th Mar 20097:00 amRNSFinal Results
26th Feb 20098:00 amRNSNotice of Results
19th Jan 20097:00 amRNSYear end trading update
18th Dec 200812:38 pmRNSKevin Steeds
4th Dec 20087:00 amRNSDirector/PDMR Shareholding
30th Oct 20081:33 pmRNSChange of Adviser Name
16th Sep 20087:00 amRNSInterim Results
2nd Sep 20082:00 pmRNSInterim Board role change
18th Aug 20084:12 pmRNSNotice of Results
18th Aug 20081:13 pmRNSHolding(s) in Company
13th Aug 20082:16 pmRNSHolding(s) in Company
6th Aug 20082:56 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSHalf year trading update
24th Jun 200810:44 amRNSDirector/PDMR Shareholding
12th Jun 20081:22 pmRNSDirector/PDMR Shareholding
20th May 20081:25 pmRNSAGM Statement
23rd Apr 200812:59 pmRNSAnnual Report & AGM
17th Apr 20087:00 amRNSAdditional Listing / TVR
28th Mar 20086:11 pmRNSAdditional listing / TVR
25th Mar 20084:04 pmRNSDirector/PDMR Shareholding
19th Mar 20088:35 amRNSDirector/PDMR Shareholding
18th Mar 200810:40 amRNSPerformance Share Option Plan
18th Mar 20087:01 amRNSFinal Results
26th Feb 20087:01 amRNSTotal Voting Rights
13th Feb 200811:03 amRNSNotice of Results
17th Jan 200810:53 amRNSTransaction in Own Shares
16th Jan 20083:03 pmRNSDirector/PDMR Shareholding
16th Jan 20082:19 pmRNSTransaction in Own Shares
16th Jan 200810:54 amRNSTransaction in Own Shares
15th Jan 20087:00 amRNSTrading Statement
3rd Jan 20084:56 pmRNSNotification of Interests
21st Dec 20078:05 amRNSChange of Adviser
14th Dec 200711:10 amRNSDirector/PDMR Shareholding
30th Nov 20073:29 pmRNSTotal Voting Rights
24th Oct 20071:30 pmRNSDirector/PDMR Shareholding
24th Oct 20077:00 amRNSPerformance Share Option Plan
23rd Oct 20077:01 amRNSAcquisition
2nd Oct 20079:59 amRNSTransactions in own shares
26th Sep 200711:35 amRNSAdditional Listing
17th Sep 20077:01 amRNSAcquisition
11th Sep 20077:01 amRNSInterim Results
31st Aug 20075:08 pmRNSTVR Update
30th Aug 20079:15 amRNSAdoption of IFRS
20th Aug 20072:53 pmRNSNotice of Results
13th Aug 20074:40 pmRNSRule 26
30th Jul 20071:55 pmRNSAdditional Listing
20th Jul 200710:00 amRNSHolding(s) in Company
12th Jul 20077:00 amRNSTrading Statement
9th Jul 20072:06 pmRNSTotal Voting Rights
6th Jul 20077:01 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.